1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Indian Diabetes Market Report: Epidemiology, Patients, Prevalence, Oral Anti-diabetics, Insulin and Diagnostics

Indian Diabetes Market Report: Epidemiology, Patients, Prevalence, Oral Anti-diabetics, Insulin and Diagnostics

  • March 2013
  • -
  • International Market Analysis Research and Consult
  • -
  • 50 pages

India with over 63 million diabetics represents the world’s second largest diabetes population after China. The Indian population that had faced under nutrition for a long time is now exposed to over nutrition and sedentary lifestyles. Coupled with a bad nutritional history and the fact that Indians are genetically more vulnerable to diabetes compared to other population groups, India’s struggle with diabetes is expected to be one of the biggest epidemics the country has ever witnessed.

India’s diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in the healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.

IMARC’s new report “Indian Diabetes Market Report: Epidemiology, Patients, Prevalence, Oral Anti-diabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the Indian diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in India. The report has segmented the Indian diabetes market into three segments - Oral Anti-diabetics, Insulin and Diabetes Diagnostics. For each of the aforementioned categories, the report provides historical and future market sales, performance of key classes and the performance of top players.
The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Indian diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Indian diabetes market in some form or the other.

What we have achieved in this report:

Comprehensive situation analysis of the Indian diabetes epidemiology and its dynamics:
Focus of the Analysis:
• Historical, current and future prevalence of diabetes in India
• Historical, current and future prevalence of type-1 and type-2 diabetes in India
• Historical, current and future prevalence of diabetes in the urban and rural regions in India
• Historical, current and future prevalence of diabetes among males and females in India
• Historical, current and future prevalence of diabetes among various age groups in India
• Historical, current and future diagnosis rates for diabetes in India
• Historical, current and future drug treatment rates for diabetes in India

Comprehensive situation analysis of the Indian Oral Anti-diabetics market and its dynamics:
Focus of the Analysis:
• Performance of the Oral Anti-diabetics market in India
• Performance of key classes
• Performance of key players
• Market outlook

Comprehensive situation analysis of the Indian Insulin market and its dynamics:
Focus of the Analysis:
• Performance of the Insulin market in India
• Performance of key classes
• Performance of key players
• Market outlook

Comprehensive situation analysis of the diabetes diagnostics market and its dynamics:
Focus of the Analysis:
• Performance of the diabetes diagnostics market in India
• Performance of key classes
• Performance of key players
• Market outlook

Information Sources:

Information has been sourced from both primary and secondary sources:
• Primary sources include industry surveys and face to face/telephone interviews with physicians and industry experts.
• Secondary sources include proprietary databases and search engines. These sources include company websites, reports, books, trade journals, magazines, white papers, Industry Portals, government sources and access to more than 4000 paid databases.

Forecasting Methodology:

IMARC generates its product and market forecasts utilizing its extensive database of macroeconomic and sector specific data. The initial baseline forecast is generated with the most recent market data. After an initial baseline forecast, all future macroeconomic and sector specific events and assumptions are taken into account to generate the final forecast.

Table Of Contents

Indian Diabetes Market Report: Epidemiology, Patients, Prevalence, Oral Anti-diabetics, Insulin and Diagnostics
Table of Contents

1 Research Methodology

2 Executive Summary

3 Diabetes Disease Overview

3.1 What is Diabetes?
3.2 Diabetes Diagnosis and Treatment
3.2.1 Diagnosis
3.2.2 Treatment
3.3 Diabetes Complications

4 Factors Driving the Diabetes Market in India

4.1 Increasing Obesity Levels
4.2 Urbanization
4.3 India has the Second Largest Diabetes Patient Base in the World
4.4 India Represents One of the Fastest Growing Markets Globally
4.5 Improving Diagnosis and Treatment Rates

5 The Indian Diabetes Epidemiology

5.1 Diabetes Population and Prevalence Rates
5.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
5.3 Population and Prevalence Rates by Region (Urban and Rural)
5.4 Population and Prevalence Rates by Gender
5.5 Population and Prevalence Rates by Age Group
5.6 Diabetes Diagnosis and Drug Treatment Rates

6 Indian Diabetes Market

6.1 Historical Market Trends (2005-2012)
6.2 Market Breakup by Segment (2005-2012)
6.3 The Indian Oral Anti-diabetics Market
6.3.1 Historical Market Trends (2005-2012)
6.3.2 Market Breakup by Class (2005-2012)
6.3.3 Market Shares of Key Players
6.3.4 Market Outlook (2013-2018)
6.4 The Indian Insulin Market
6.4.1 Historical Market Trends (2005-2012)
6.4.2 Market Breakup by Class
6.4.3 Market Shares of Key Players
6.4.4 Market Outlook (2013-2018)
6.5 Market Outlook (2013-2018)

7 Indian Diabetes Diagnostics Market

7.1.1 Historical Market Trends (2005-2012)
7.1.2 Market Segmentation
7.1.3 Market Shares of Key Players
7.1.4 Market Outlook (2012-2017)




List of Figures

Figure 3 1: The Impact of Diabetes on the Human Body
Figure 3 2: Diabetes Complications
Figure 4 1: India: Overweight and Obese Population (in Millions), 2005, 2010 and 2015
Figure 4 2: Body Mass Index and Relative Risk of Type-2 Diabetes
Figure 4 3: Global: Breakup of Diabetes Patients by Region (in %), 2011 and 2030
Figure 5 1: India: Total Number of Diabetes Patients (in Millions), 2004, 2008 and 2012
Figure 5 2: India: Total Number of Diabetes Patients (in Millions), 2016, 2020, 2024, 2028 and 2032
Figure 5 3: India (Type1 and Type2): Total Number of Diabetes Patients (in Millions), 2004, 2008 and 2012
Figure 5 4: India (Type1 and Type2): Total Number of Diabetes Patients (in Millions) 2016, 2020, 2024, 2028 and 2032
Figure 5 5: India (Urban and Rural): Total Number of Diabetes Patients (in Millions), 2004, 2008 and 2012
Figure 5 6: India (Urban and Rural): Total Number of Diabetes Patients (in Millions), 2016, 2020, 2024, 2028 and 2032
Figure 5 7: India (Male and Female): Total Number of Diabetes Patients (in Millions), 2004, 2008 and 2012
Figure 5 8: India (Male and Female): Total Number of Diabetes Patients (in Millions), 2016, 2020, 2024, 2028 and 2032
Figure 5 9: India: Total Number of Diabetes Patients by Age Group (20-39), (40-59) and (60-79) (in Millions), 2004, 2008 and 2012
Figure 5 10: India: Total Number of Diabetes Patients by Age Group (20-39), (40-59) and (60-79) (in Millions), 2016, 2020, 2024, 2028 and 2032
Figure 5 11: India: Total Diagnosed and Drug Treated Diabetes Population (in Millions), 2004, 2008 and 2012
Figure 5 12: India: Total Diagnosed and Drug Treated Diabetes Population (in Millions), 2016, 2020, 2024, 2028 and 2032
Figure 6 1: India: Diabetes Market (in Million US$), 2005-2012
Figure 6 2: India: Diabetes Market: Share of Oral Anti-diabetics and Insulin (in %), 2005-2012
Figure 6 3: India: Oral Anti-diabetics Market (in Million US$), 2005-2012
Figure 6 4: India: Oral Anti-diabetics Market: Sales Share of Key Classes (in %), 2005-2012
Figure 6 5: India: Oral Anti-diabetics Market: Sales Share of Key Players (in %), 2012
Figure 6 6: India: Oral Anti-diabetics Market Forecast (in Million US$), 2012-2018
Figure 6 7: India: Oral Anti-diabetics Market Forecast: Sales Share of Key Classes (in %), 2012, 2015 and 2018
Figure 6 8: India: Insulin Market (in Million US$), 2005-2012
Figure 6 9: India: Insulin Market: Sales Share of Key Classes (in %), 2012
Figure 6 10: India: Insulin Market: Sales Share of Key Players (in %), 2012
Figure 6 11: India: Insulin Market Forecast (in Million US$), 2012-2018
Figure 6 12: India: Insulin Market Forecast: Sales Share of Key Classes (in %), 2012, 2015 and 2018
Figure 6 13: India: Diabetes Market Forecast (in Million US$), 2013-2018
Figure 6 14: India: Diabetes Market Forecast: Share of Oral Anti-diabetics and Insulin (in %), 2013-2018
Figure 7 1: India: Glucose Monitoring Market (in Million US$), 2005-2012
Figure 7 2: India: Glucose Monitoring Market: Sales Share by Segment (in %), 2012
Figure 7 3: India: Glucose Monitoring Market: Sales Share of Key Players (in %), 2012
Figure 7 4: India: Glucose Monitoring Market Forecast (in Million US$), 2012-2018





List of Tables

Table 2 1: India: Diabetes Epidemiology: Executive Summary
Table 2 2: India: Diabetes Market: Executive Summary
Table 3 1: Diagnosis of Diabetes
Table 4 1: India: Overweight and Obesity Statistics, 2005, 2010 and 2015
Table 4 2: India: Urban and Rural Population Breakup (in Millions), 1991, 2001 and 2011
Table 4 3: Global: Diabetes Population Breakup by Country (in 000's), 2011 and 2030
Table 4 4: Global: Market Size and Growth Rates of Top Emerging and Developed Diabetes Drug Markets, 2012
Table 5 1: India: Total Prevalence and Number of Diabetes Patients, 2004, 2008, 2012, 2016, 2020, 2024, 2028 and 2032
Table 5 2: India (Type1 and Type2): Total Prevalence and Number of Diabetes Patients, 2004, 2008, 2012, 2016, 2020, 2024, 2028 and 2032
Table 5 3: India (Urban and Rural): Total Prevalence and Number of Diabetes Patients, 2004, 2008, 2012, 2016, 2020, 2024, 2028 and 2032
Table 5 4: India (Male and Female): Total Prevalence and Number of Diabetes Patients, 2004, 2008, 2012, 2016, 2020, 2024, 2028 and 2032
Table 5 5: Total Prevalence and Number of Diabetes Patients by Age Group (20-39), (40-59) and (60-79) (In Millions), 2004, 2008, 2012, 2016, 2020, 2024, 2028 and 2032
Table 5 6: India: Total Diagnosed and Drug Treated Diabetes Population, 2004, 2008, 2012, 2016, 2020, 2024, 2028 and 2032
Table 6 1: India: Oral Anti-diabetics Market: Sales of Key Classes (in Million US$), 2005-2012
Table 6 2: India: Oral Anti-diabetics Market Forecast: Sales of Key Classes (in Million US$), 2012, 2015 and 2018
Table 6 3: India: Insulin Market: Sales of Key Classes (in 000' US$), 2005-2012
Table 6 4: India: Insulin Market Forecast: Sales of Key Classes (in Million US$), 2012, 2015 and 2018

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Markets for Diabetes Therapeutics and Diagnostics

Global Markets for Diabetes Therapeutics and Diagnostics

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Analyze the market for drugs used in the treatment of diabetes, it's technology and the industry as a whole - Identify important trends and provide sales forecasts by product categories ...

European Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2016 - MedView

European Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2016 - MedView

  • $ 4995
  • Industry report
  • September 2016
  • by iData Research, Inc.

The European diabetes diagnosis, treatment and drug delivery market increased in 2015 and growth is expected to persist over the forecast period. Market growth will be driven by the growing prevalence ...

Diabetic Gastroparesis  - Market Insights, Epidemiology and Market Forecast-2023

Diabetic Gastroparesis  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Diabetic Gastroparesis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Diabetic Gastroparesis fo ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.